Gregory A. Viglianti
- Virology top 1%
- HIV Research and Treatment 19
- Immunology top 1%
- Immune Cell Function and Interaction 16
- Immunotherapy and Immune Responses 9
- Immune Response and Inflammation 9
- T-cell and B-cell Immunology 9
- Rheumatology top 2%
- Toxicology top 2%
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 5
-
- Retinoids in leukemia and cellular processes 4
-
- Herpesvirus Infections and Treatments 3
- Co-authors
- Ann Marshak‐RothsteinIan R. RifkinTimothy M. HanleyMark J. ShlomchikChristina M. LauJames I. MullinsLiliana BusconiShizuo Akira
- Cited by
- VirologyImmunologyRheumatology
- Journals
- Journal of Virology (8 papers)The Journal of Immunology (5 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Gregory A. Viglianti
42 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Virology 550
- Immunology 1.9k
- Rheumatology 391
- Toxicology 82
- Infectious Diseases 287
Countries citing papers authored by Gregory A. Viglianti
This map shows the geographic impact of Gregory A. Viglianti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Viglianti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Viglianti more than expected).
Fields of papers citing papers by Gregory A. Viglianti
This network shows the impact of papers produced by Gregory A. Viglianti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Viglianti. The network helps show where Gregory A. Viglianti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gregory A. Viglianti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 21 | |
| 2 | 2016 | 6 | |
| 3 | 2011 | 37 | |
| 4 | 2010 | 65 | |
| 5 | 2010 | 21 | |
| 6 | 2009 | 93 | |
| 7 | 2006 | 9 | |
| 8 | RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagementbreakdown → | 2005 | 641 |
| 9 | 2004 | 19 | |
| 10 | 2004 | 21 | |
| 11 | 2004 | 27 | |
| 12 | 2003 | 428 | |
| 13 | 2002 | 6 | |
| 14 | 2002 | 162 | |
| 15 | Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages. | 1998 | 37 |
| 16 | 1998 | 33 | |
| 17 | 1997 | 30 | |
| 18 | 1997 | 3 | |
| 19 | 1997 | 9 | |
| 20 | 1997 | 91 |
About Gregory A. Viglianti
Gregory A. Viglianti is a scholar working on Virology, Immunology and Periodontics, having authored 42 papers that have together received 3.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (16 papers), Immunotherapy and Immune Responses (9 papers), Immune Response and Inflammation (9 papers), T-cell and B-cell Immunology (9 papers), HIV/AIDS drug development and treatment (5 papers), Retinoids in leukemia and cellular processes (4 papers) and Herpesvirus Infections and Treatments (3 papers). The work is most often cited by research in Virology (550 citations), Immunology (1.9k citations) and Rheumatology (391 citations). Gregory A. Viglianti has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Ann Marshak‐Rothstein, Ian R. Rifkin, Timothy M. Hanley, Mark J. Shlomchik, Christina M. Lau, James I. Mullins, Liliana Busconi, Shizuo Akira, Benjamin A. Miko and Elizabeth A. Leadbetter. Their work appears in journals such as Journal of Virology, The Journal of Immunology, Journal of Biological Chemistry, Current Protocols in Immunology and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.